Antidyslipidaemic activity of Glycyrrhiza glabra in high fructose diet induced dsyslipidaemic Syrian golden hamsters

  • Santosh Kumar MauryaEmail author
  • Kanwal Raj
  • Arvind Kumar Srivastava
Original Article


The root of Glycyrrhiza glabra is a traditional medicine used mainly for the treatment of peptic ulcer, hepatitis C, pulmonary and skin diseases, although clinical and experimental studies suggest that it has several other useful pharmacological properties such as antiinflammatory, antiviral, antimicrobial, antioxidative, anticancer activities, immunomodulatory, hepatoprotective and cardioprotective effects. Glycyrrhizinic acid, a major component of licorice, has antiulcer effect by raising the local concentration of prostaglandins that promote mucous secretion and cell proliferation in the stomach. Glycyrrhizin shows hepatoprotective effect by preventing changes in cell membrane permeability, inhibiting phospholipase A2 (PLA2) and increasing survival rate of hepatocytes. Glabridin has effect in melanogenesis and inflammation by inhibiting the tyrosinase activity of melanocytes. α-glycyhrritinic acid exhibits anti-inflammatory activity by inhibiting glucocorticoid metabolism. In present study ethanolic (95%) extract of root of Glycyrrhiza glabra and its fractions were investigated for its antidyslipidaemic activity on HFD induced dyslipidaemic hamsters. Ethanolic extract and its ethyl acetate soluble, water soluble and hexane soluble fractions decreased serum level of total cholesterol by 25.9, 38.0, 39.0 and 26.3%, respectively. On the other hand ethanolic extract, ethyl acetate soluble, water soluble and hexane soluble fraction increased the serum HDL-cholesterol level by 14.8, 34.3, 27.3 and 17.2%, respectively. Ethanolic extract, ethyl acetate fraction, aqueous fraction and hexane fraction decreased triglyceride level by 31.3, 37.2, 41.2 and 28.9%, respectively. The reduction in LDL-cholesterol level by ethanolic extract, ethyl acetate soluble fraction and water soluble fraction were 43.9, 31.0, 33.4 and 24.6%, respectively.

Key Words

Glycyrrhiza glabra Dyslipidaemia High fructose diet 


  1. 1.
    Chong PH, Bachenheimer BS. Current, new and future treatments in dyslipidaemia and atherosclerosis. Drugs 2000;60(1):55–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Havel R, Rapaport E. Management of primary hyperlipidemia. N Engl J Med 1995;332:1491–1498.CrossRefPubMedGoogle Scholar
  3. 3.
    Tiwari A. Natural product antioxidants and their therapeutic potential in mitigating peroxidative modification of lipoproteins and atherosclerosis: recent development. J Med Aroma Plant Sci 1999;21:730–741.Google Scholar
  4. 4.
    Singh B, Bhat TK, Singh B. Potential therapeutic applications of some antinutritional plant secondary metabolites. J Agric Food Chem 2003;51(19):5579–5597.CrossRefPubMedGoogle Scholar
  5. 5.
    Ross IA. Medicinal plants of the world. Totowa, NJ: Humana Press Inc; 2001.Google Scholar
  6. 6.
    Vaya J, Belinky PA, Aviram M. Antioxidant Constituents from Licorice Roots: Isolation, Structure Elucidation and Antioxidative Capacity Toward LDL Oxidation. Free Radical Biol Med 1997;23(2):302–313.CrossRefGoogle Scholar
  7. 7.
    Belinky PA, Aviram M, Fuhrman B, Rosenblat M, Vaya J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 1998;137(1):49–61.CrossRefPubMedGoogle Scholar
  8. 8.
    Zhan C, Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res 2006;53(3):303–309.CrossRefPubMedGoogle Scholar
  9. 9.
    Sitohy MZ, el-Massry RA, el-Saadany SS, Labib SM. Metabolic effects of licorice roots (Glycyrrhiza glabra) on lipid distribution pattern, liver and renal functions of albino rats. MS Nahrung 1991;35(8):799–806.CrossRefGoogle Scholar
  10. 10.
    Wang GS, Han ZW. The protective action of glycyrrhiza flavonoids against carbon tetrachloride hepatotoxicity in mice. Yao Xue Xue Bao 1993;28(8):572–576.PubMedGoogle Scholar
  11. 11.
    Kiso Y, Tohkin M, Hikino H. Mechanism of antihepatotoxic activity of glycyrhhizin, I: Effect on free radical generation and lipid peroxidation. Planta Medica 1984;50:298–302.CrossRefPubMedGoogle Scholar
  12. 12.
    Haraguchi H, Ishikawa H, Mizutani K, Tamura Y, Kinoshita T. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 1998;6(3):339–347.CrossRefPubMedGoogle Scholar
  13. 13.
    Krausse R, Bielenberg J, Blaschek W, Ullmann U. In vitro anti-Helicobacter pylori activity of Extractum liquiritiae, glycyrrhizin and its metabolites. J Antimicrob Chemother 2004;54(1):243–246.CrossRefPubMedGoogle Scholar
  14. 14.
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterolin Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem 1972;18(6):499–502.PubMedGoogle Scholar
  15. 15.
    Park O, Cesar D, Faix D, Wu K, Shackleton C, Hellerstein M. Mechanism of fructose-induced hypertriglyceridemia in the rat: Activation of hepatic pyruvate dehydrogenase kinase. Biochem J 1992;282:753–757.PubMedGoogle Scholar
  16. 16.
    Zavaroni I, Chen Y, Reaven GM. Studies of the mechanisms of fructose-induce hypertriglyceridemia in the rat. Metabolism 1982;31:1077–1083.CrossRefPubMedGoogle Scholar
  17. 17.
    Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinol 2005;145(2):548–555.CrossRefGoogle Scholar
  18. 18.
    Tan BK, Tan CH, Pushparaj PN. Anti-diabetic activity of the semipurified fractions of Averrhoa bilimbi in high fat diet fedstreptozotocin induced diabetic rats. Life Sci 2005;76:2827–2839.CrossRefPubMedGoogle Scholar
  19. 19.
    Betteridge J. Lipid disorders in diabetes mellitus. In: Pickup, JC Williams, G. (Eds.), Textbook of Diabetes. second ed. London: Blackwell Science; 1997.Google Scholar
  20. 20.
    Ghatak A, Asthana OP. Recent trends in hyperlipoproteinemias and its pharmacotherapy. Ind J Pharmacol 1995;27:14–29.Google Scholar
  21. 21.
    Brown GB, Xue Qiao, Sacco DE, Alberts JJ. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87:1781–1791.PubMedGoogle Scholar
  22. 22.
    Visavadiya NP, Narasimhacharya AVRL. Hypocholesterolaemic and antioxidant effects of Glycyrrhiza glabra (Linn) in rats. Mol Nutr Food Res 2006;50:1080–1086.CrossRefPubMedGoogle Scholar
  23. 23.
    Howell TJ, MacDougall DE, Jones PJH. Phytosterols partially explain differences in cholesterol metabolism caused by corn or olive oil feeding. J Lipid Res 1998;39:892–900.PubMedGoogle Scholar
  24. 24.
    Ikeda I, Sugano M. Inhibition of cholesterol absorption by plant sterols for mass intervention. Curr Opin Lipidol 1998;9:527–531.CrossRefPubMedGoogle Scholar
  25. 25.
    Harwood JHJ, Chandler CE, Pellarin LD, Bangerter FW, RW Wilkins, Long CA, et al. Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin betatigogenin cellobioside (CP-88818; tiqueside). J Lipid Res 1993;34:377–395.PubMedGoogle Scholar
  26. 26.
    Oakenfull DG, Sidhu GS. Could saponins be a useful treatment for hypercholesterolaemia? Eur J Clin Nutr 1990;44:79–88.PubMedGoogle Scholar
  27. 27.
    Warnholtz A, Mollnau H, Oelze M, Wendt M, Munzel T. Hypolipidemic and antioxidant activities of Asparagus racemosus in hypercholesteremic rats. Curr Hyperten Reports 2001;3:53–60.CrossRefGoogle Scholar
  28. 28.
    Fukushima M, Ohashi T, Fujiwara Y, Sonoyama K, Nakano M. Cholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med 2001;226:758–765.Google Scholar
  29. 29.
    Venkatesan N, Devaraj SN, Devaraj H. Increased binding of LDL and VLDL to apo B, E receptors of hepatic plasma membrane of rats treated with fibernat. Eur J Nutr 2003;42:262–271.CrossRefPubMedGoogle Scholar
  30. 30.
    Gotto AM. Triglyceride: The Forgotten Risk Factor. Circulation 1998;97:1027–1028.PubMedGoogle Scholar
  31. 31.
    Han LK, Zheng YN, Xu BJ, Okuda H, Kimura Y. Saponins from Platycodi Radix ameliorate high fat diet-induced obesity in mice. J Nutr 2002;132:2241–2245.PubMedGoogle Scholar
  32. 32.
    Staels B, Dallongville J, Auwerx J, Schoonjans K, Leitersdorf E. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088–2093.PubMedGoogle Scholar
  33. 33.
    Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arterioscler Thromb Vasc Biol 1988;8:737–741.Google Scholar
  34. 34.
    Assmann G, Nofer J. Atheroprotective effects of high-density lipoproteins. Annu Rev Med 2003;54:321–341.CrossRefPubMedGoogle Scholar
  35. 35.
    Moundras C, Behr SR, Remesy C, Demigne C. Fecal losses of sterols and bile acids induced by feeding rats Guar gum are due to greater pool size and liver bile acid secretion. J Nutr 1997;127:1068–1076.PubMedGoogle Scholar
  36. 36.
    Vinson JA, Hu S-J, Jung S, Stanski AM. A citrus extract plus ascorbic acid decreases lipids, lipid peroxides, lipoprotein oxidative susceptibility, and atherosclerosis in hypercholesterolemic hamsters. J Agric Food Chem. 1998;46:1453–1459.CrossRefGoogle Scholar
  37. 37.
    Daniel RS, Devi KS, Augusti KT. Mechanism of action of antiatherogenic and related effects of Ficus bengalensis Linn. flavonoids in experimental animals. Ind J Exp Biol 2003;41:296–303.Google Scholar

Copyright information

© Association of Clinical Biochemists of India 2009

Authors and Affiliations

  • Santosh Kumar Maurya
    • 1
    Email author
  • Kanwal Raj
    • 2
  • Arvind Kumar Srivastava
    • 1
  1. 1.Division of BiochemistryCentral Drug Research InstituteLucknowIndia
  2. 2.Medicinal and Process Chemistry DivisionCentral Drug Research InstituteLucknowIndia

Personalised recommendations